Influence of Episil for Oral Cavity of Patients undergoing Hematopoietic Stem Cell Transplantation

Episil - Episil

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000040091

Enrollment

Registered

2020-06-01

Start date

2020-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients of hematopoietic stem cell transplantaion

Interventions

use Episil or not

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are going to undergo hematopoietic stem cell transplantation at Toranomon Hospital

Exclusion criteria

Exclusion criteria: pediatric patients

Design outcomes

Primary

Measure	Time frame
Occurrence of oral mucositis	—

Countries

Japan

Contacts

Public ContactMieko Mizutani

Toranomon Hospital Department of Dentistry

m.mizutani@toranomon.gr.jp03-3588-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026